Long intergenic non-protein coding RNA 592 (LINC00592)

Long intergenic non-protein coding RNA 592 (LINC00592) is classified as a long non-coding RNA (lncRNA), based on genomic annotations from sources such as NCBI Gene and Ensembl[1][3][5]. It is located on chromosome 12q13 and is annotated as a human gene, but as of this review, its specific functions, disease associations, biological activities, and clinical utility remain uncharacterized in the primary literature and biomedical databases. There is no evidence LINC00592 is considered a therapeutic target, nor are there reports on drugs, mechanisms, or clinical biomarkers directly linked to this molecule. This profile distinguishes it from other better-studied lncRNAs such as LINC01116, which have clearly established roles in cancer biology and clinical prognosis[2]. Notes: - All available information confirms LINC00592 is a valid, non-misspelled molecular entity corresponding to a specific lncRNA gene[1][3][5]. - No evidence indicates this target is currently used or investigated as a therapeutic target, biomarker, or clinical intervention point. - Alias redundancy is minimal; the abbreviation LINC00592 is consistent across all major databases[1][3][5]. - If you seek information on a functionally relevant/characterized lncRNA, such as LINC01116, consult sources like [2] for detailed roles in cancer. - Future research may change classification or roles if novel biological insights are discovered.

Other names

LINC00592long intergenic non-protein coding RNA 592

Null (no known drugs or clear mechanism of action documented)